CN1136961A - Ointment for curing putrefactive wound, producing method and use thereof - Google Patents
Ointment for curing putrefactive wound, producing method and use thereof Download PDFInfo
- Publication number
- CN1136961A CN1136961A CN 96115776 CN96115776A CN1136961A CN 1136961 A CN1136961 A CN 1136961A CN 96115776 CN96115776 CN 96115776 CN 96115776 A CN96115776 A CN 96115776A CN 1136961 A CN1136961 A CN 1136961A
- Authority
- CN
- China
- Prior art keywords
- wound
- ointment
- putrefactive
- curing
- pheretima
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
An ointment for treating infected suppurative wound, bed sore, necrotic fasciitis, and infected burn or scald with unique curative effect is made of metronidazole, anisodamine, alum, gypsum, honey, alpha-chymotrypsin, and "Dilongjinshanye" liquid and serves to reduce secretion and edema, promote the growth of epithelial tissue, and resist infection.
Description
The present invention relates to a kind of cream drug, production method and application thereof for the treatment of skin trauma.
In the prior art, the medicine of treatment infection suppurates wound surface has " JINGWANHONG " and " band bed sore ointment "." JINGWANHONG " is a kind of medicine of specially controlling burn, scalding, to burn with scald effectively, but many, the frowziness of its secretions, granulation edema when using during to infection suppurates." band bed sore ointment " is the medicine of specially controlling decubital ulcer, has the effect of granulation promoting removing the necrotic tissue, but the granulation poor growth." JINGWANHONG " and " decubital ulcer skin ulcer cream " is all invalid to necrotizing fasciitis.
The objective of the invention is to disclose a kind of to the infection suppurates wound surface, II ° of III ° of decubital ulcer, burn or scald infection, necrotizing fasciitis be double to be controlled, the ointment for curing putrefactive wound that effective percentage and cure rate are all high, production method and application.
The present invention realizes by following measure.
Ointment for curing putrefactive wound, production method and application
The ointment for curing putrefactive wound composition
Medicine name one dosage
Metronidazole 2.5 grams
Anisodamine 0.05 gram
Alumen 100 grams
Gypsum Fibrosum 100 grams
Mel 500 grams
Chymetin 0.05 gram
Pheretima leachate 1.5 grams
The production method of ointment for curing putrefactive wound
Metronidazole, mountain gelsemium henbane alkali, Alumen, Gypsum Fibrosum are mixed in proportion, add in the Mel in proportion behind the mix homogeneously, stir be heated to 40 ℃ 4-6 minute, make its mix homogeneously, cool again to below 30 ℃, add Chymetin and Pheretima leachate more in proportion, mix, produce thick ointment, be ointment for curing putrefactive wound.
The application of ointment for curing putrefactive wound
Ointment for curing putrefactive wound is used for the treatment of the infection suppurates wound surface, II ° of III ° of decubital ulcer, burn or scald infection and necrotizing fasciitis.
Directly ointment for curing putrefactive wound is applied in affected part during clinical practice or gauze is soaked ointment for curing putrefactive wound and stick on affected part.
The effect of ointment for curing putrefactive wound
Ointment for curing putrefactive wound to the effective percentage of treatment infection suppurates wound surface be 100%, cure rate 85%; Effective percentage to II ° of III ° of decubital ulcer of treatment is 100%, and cure rate reaches 80%, and III ° of decubital ulcer should cooperate Surgery Treatment; The treatment for the treatment of two routine necrotizing fasciitis also there is significant curative effect.Ointment for curing putrefactive wound has tangible removing the necrotic tissue and promoting granulation effect, can restrain, and reduces secretions, alleviates tissue edema, promotes the epithelial tissue growth, and anti-infection ability is strong, odorless, tasteless, have no side effect and anaphylaxis.Especially to some application " JINGWANHONG ", band bed sore ointment " patient that fails to respond to any medical treatment, use ointment for curing putrefactive wound and can play beyond thought surprising effect.
Be described in further detail the present invention below in conjunction with embodiment.In an embodiment, the weight of each material is that a dosage, unit are gram, percentages.
Embodiment
The ointment for curing putrefactive wound composition
Medicine name one dosage percentage ratio
Metronidazole (A) 2.5 grams 0.348
Anisodamine (B) 0.05 gram 0.007
Alumen (C) 100 grams 13.935
Gypsum Fibrosum (D) 100 grams 13.935
Mel (E) 500 grams 69.677
Chymetin (F) 0.05 gram 0.007
Pheretima leachate (G) 15 grams 2.090
The production method of ointment for curing putrefactive wound
Metronidazole, anisodamine, Alumen, Gypsum Fibrosum are mixed by above-mentioned weight or percentage by weight, add in the Mel in proportion behind the mix homogeneously and stir, be heated to then 40 ℃ 4-6 minute, make its mix homogeneously, cool again to below 30 ℃, under stirring, add Chymetin and Pheretima leachate by above-mentioned weight or percentage ratio again, stir, become thick paste, i.e. ointment for curing putrefactive wound.
The preparation of Pheretima leachate
Fresh clean Pheretima 30 grams are put into glass (wide-mouth) bottle, put into 10 gram white sugar, use filtered through gauze after one hour, it is standby to take out leachate.New fresh Pheretima after cleaning takes up an area of 75% of dragon, white sugar gross weight, and white sugar takes up an area of 25% of dragon, white sugar gross weight.The weight ratio that is Pheretima and white sugar is 3: 1.
The application of ointment for curing putrefactive wound
Be used for the treatment of infection suppurates wound surface, II ° III ° decubital ulcer, water wound or scald and necrotizing fasciitis.
Can directly ointment for curing putrefactive wound be applied in patient's affected part or gauze be soaked ointment for curing putrefactive wound during clinical practice and stick on patient's affected part.
The effect of ointment for curing putrefactive wound
Ointment for curing putrefactive wound to the effective percentage of treatment infection suppurates wound surface be 100%, cure rate reaches 85%; Effective percentage to the treatment decubital ulcer is 100%, control Yu leads and reaches 80%, should cooperate Surgery Treatment to III ° of decubital ulcer; The treatment necrotizing fasciitis also there is obvious curative effects.It has tangible removing the necrotic tissue and promoting granulation effect, can restrain, and reduces secretions, alleviates tissue edema, promotes the epithelial tissue growth, and anti-infection ability is strong, nonpoisonous and tasteless, have no side effect and anaphylaxis.Particularly the patient that some application " JINGWANHONG ", " band bed sore ointment " are failed to respond to any medical treatment, can reach beyond thought surprising effect when using ointment for curing putrefactive wound.
Claims (5)
1, a kind of ointment for curing putrefactive wound, it is characterized in that: it is made up of metronidazole (A), anisodamine (B), Alumen (C), Gypsum Fibrosum (D), Mel (E), Chymetin (F), Pheretima leachate (G), the content of metronidazole (A) be 2.5 the gram, anisodamine (B) content be 0.05 the gram, Alumen (C) content be 100 the gram, Gypsum Fibrosum (D) content be 100 the gram, Mel (E) content be 500 the gram, Chymetin (F) content be 0.05 the gram, Pheretima leachate (G) content be 15 the gram.
2, a kind of production method of ointment for curing putrefactive wound, it is characterized in that: metronidazole (A), anisodamine (B), Alumen (C), Gypsum Fibrosum (D) are mixed in proportion the back add in the Mel (E) in the peace ratio, be heated with stirring to 40 ℃ and made its mix homogeneously in 4-6 minute, cool again to below 30 ℃, add Chymetin (F) and Pheretima leachate (G) more in proportion, mix standby.
3, according to the production method of claims 2 described a kind of ointment for curing putrefactive wound, it is characterized in that: Pheretima leachate (G) is that new fresh Pheretima adds white sugar and makes after filtration.
4, according to claim 2 or 3 described Pheretima leachates (G), it is characterized in that: the weight ratio of Pheretima and white sugar is 3: 1.
5, the described a kind of ointment for curing putrefactive wound of claim 1 to 3 is used for the treatment of the infection suppurates wound surface, decubital ulcer, ring dead property fascitis, burn or scald infection.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN96115776A CN1067276C (en) | 1996-04-30 | 1996-04-30 | Ointment for curing putrefactive wound, producing method and use thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN96115776A CN1067276C (en) | 1996-04-30 | 1996-04-30 | Ointment for curing putrefactive wound, producing method and use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1136961A true CN1136961A (en) | 1996-12-04 |
| CN1067276C CN1067276C (en) | 2001-06-20 |
Family
ID=5122994
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN96115776A Expired - Fee Related CN1067276C (en) | 1996-04-30 | 1996-04-30 | Ointment for curing putrefactive wound, producing method and use thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1067276C (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100358538C (en) * | 2005-01-25 | 2008-01-02 | 刘述余 | Medicine for treating burn and scald |
| CN103110627A (en) * | 2011-11-16 | 2013-05-22 | 高尔医药科技(上海)有限公司 | Application of medicinal composition |
-
1996
- 1996-04-30 CN CN96115776A patent/CN1067276C/en not_active Expired - Fee Related
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100358538C (en) * | 2005-01-25 | 2008-01-02 | 刘述余 | Medicine for treating burn and scald |
| CN103110627A (en) * | 2011-11-16 | 2013-05-22 | 高尔医药科技(上海)有限公司 | Application of medicinal composition |
| CN103110627B (en) * | 2011-11-16 | 2016-05-25 | 高尔医药科技(上海)有限公司 | A kind of application of pharmaceutical composition |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1067276C (en) | 2001-06-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2312558C (en) | Collagen containing tissue adhesive | |
| CN101612278B (en) | Medicine for external application for treating pyogenic type contaminated wounds | |
| CN105311332A (en) | Ulcer stopping and tissue regeneration promoting powder | |
| IT201900000385A1 (en) | COMPOSITION FOR THE TREATMENT OF SKIN INJURIES AND IRRITATIONS | |
| CN1067276C (en) | Ointment for curing putrefactive wound, producing method and use thereof | |
| CN1246021C (en) | Non-scar plaster for treating trauma and its preparing process and usage | |
| CN100508992C (en) | Chinese medicine for treating trauma, burns and scalds | |
| CN1772077A (en) | Medicine liquid for treating burns and scalds and its prepn | |
| CN1268357C (en) | Medicine composition for treating furuncle, abscess, carbuncle, furuncle, burn and scald | |
| CN1165011A (en) | Enternal use adhesive plaster for treatment of rheumatism | |
| CN1173355A (en) | Recovering liquid for oral cavity ulcer | |
| CN1258367C (en) | Medicine for treating trauma | |
| CN1127970C (en) | Ointment for treating burn and its preparing process | |
| CN1199666C (en) | Medicine 'Suyusan' for treating intractable ulcer | |
| CN1061888C (en) | Medicine for treating intractable ulcer and its preparing process | |
| RU2806724C1 (en) | Wound-healing film with prolonged action | |
| CN107802895A (en) | A kind of scar repair material and its preparation method and application | |
| CN1332701C (en) | Externally applied Chinese medicinal formulation for treating bone fracture | |
| RU2194509C1 (en) | Powder | |
| RU2036658C1 (en) | Method of treating infected wound | |
| CN108310220B (en) | Pharmaceutical composition for treating bedsore and preparation method and application thereof | |
| CN1299719C (en) | Compound preparation for treating cervicitis | |
| CN1843375A (en) | Traditional Chinese medicine for treating lower limb ulcer | |
| CN101249185A (en) | Medicament for curing burns, and trauma infection contamination | |
| CN114010669A (en) | Ointment for removing putrefaction and promoting tissue regeneration and preparation method and application thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |